Our Pricing

Can I Stay on Low Dose Wegovy? UK Clinical Guidance and Maintenance Dosing

Many patients ask whether they can stay on low dose Wegovy for long-term weight maintenance rather than escalating to higher doses. While Wegovy's licensed dosing schedule typically progresses to 2.4mg weekly, some individuals achieve their weight goals on lower doses and wish to remain there. This page provides expert UK clinical guidance on low dose Wegovy maintenance, regulatory considerations, and the cheapest UK pricing from Cured Pharmacy.

Understanding Low Dose Wegovy and the Standard Dosing Schedule

Wegovy (semaglutide) is licensed in the UK for chronic weight management with a specific dose escalation protocol. The standard schedule begins at 0.25mg weekly, increasing every four weeks through 0.5mg, 1mg, 1.7mg, and finally reaching the maintenance dose of 2.4mg weekly [1]. This gradual titration minimises gastrointestinal side effects whilst allowing the body to adapt to semaglutide's appetite-suppressing effects.

Low dose Wegovy typically refers to the 0.25mg, 0.5mg, or 1mg strengths used during the escalation phase. Some patients experience significant weight loss and appetite control at these lower doses and question whether continuing at this level is appropriate. The STEP clinical trials primarily evaluated the 2.4mg dose, where participants lost an average of 14.9% of their body weight over 68 weeks [1]. However, individual responses vary considerably, and some patients achieve their target weight loss on lower doses.

From a regulatory perspective, Wegovy's UK marketing authorisation specifies the 2.4mg dose as the recommended maintenance dose. Prescribers may exercise clinical judgement to adjust dosing based on individual patient response, tolerability, and weight management goals, but this represents off-label use of the lower dose strengths for long-term maintenance [2].

Can You Stay on Low Dose Wegovy Long-Term? Clinical Considerations

Whether you can remain on low dose Wegovy depends on several clinical factors that your UK prescriber will assess. The primary consideration is whether the lower dose continues to provide effective weight management and metabolic benefit. If you've reached your target weight and maintained it for several months on a lower dose with good tolerability, your prescriber may support continuing at that level [2].

Clinical evidence specifically for long-term low dose Wegovy maintenance is limited, as the pivotal STEP trials focused on the 2.4mg dose. However, real-world clinical experience suggests some patients maintain weight loss on lower doses, particularly when combined with sustained lifestyle modifications. Your prescriber will evaluate your weight trajectory, any weight regain, appetite control, and metabolic markers like HbA1c if you have type 2 diabetes.

Tolerability is another crucial factor. If you experience persistent nausea, vomiting, or other gastrointestinal side effects at higher doses, remaining on a lower dose may be clinically appropriate. However, if you've plateaued in your weight loss before reaching your goal, dose escalation to 2.4mg may be necessary to achieve further benefit [3]. Regular monitoring with your prescriber ensures your dosing strategy aligns with your individual clinical response.

Low Dose Wegovy and Weight Regain Risk

One concern with staying on low dose Wegovy is the potential for weight regain. The STEP 4 trial demonstrated that discontinuing semaglutide led to significant weight regain, with participants regaining approximately two-thirds of their lost weight within one year [1]. Whilst this study examined complete discontinuation rather than dose reduction, it highlights the importance of maintaining adequate pharmacological support.

If you remain on a sub-therapeutic dose for your individual physiology, you may experience gradual weight regain over time. This doesn't necessarily mean everyone requires 2.4mg — some individuals genuinely maintain on lower doses — but it underscores the need for ongoing clinical monitoring. Your UK prescriber should review your weight at least every three months when using low dose Wegovy for maintenance to detect any upward trends early.

Low Dose Wegovy UK Prescribing: What Your Clinician Will Consider

UK prescribers follow NICE guidance and MHRA licensing when prescribing Wegovy, which recommends the 2.4mg maintenance dose. However, clinical practice allows for individualised dosing based on patient-specific factors. When you request to stay on low dose Wegovy, your prescriber will document their clinical rationale, which may include achieving target weight loss, dose-limiting side effects, or patient preference balanced against clinical effectiveness [2].

Your consultation will typically cover your weight loss journey to date, percentage of body weight lost, current BMI, any comorbidities like type 2 diabetes or hypertension, and how well controlled these are. If you've lost 5% or more of your initial body weight and maintained this for at least three months on a lower dose, this supports continuation. Conversely, if weight loss has stalled significantly below your target, dose escalation may be recommended.

Prescribers at Cured Pharmacy conduct thorough clinical assessments to determine the most appropriate Wegovy dosing for your circumstances. All prescribing decisions are made by UK-registered clinicians following GMC and GPhC professional standards. If low dose Wegovy maintenance is clinically suitable for you, this will be clearly documented in your patient record and prescription.

Low Dose Wegovy Pricing UK: Cheapest Options at Cured Pharmacy

Wegovy pricing in the UK varies by dose strength and supplier. At Cured Pharmacy, we offer the cheapest low dose Wegovy prices in the UK, starting from £69.00 for the lower dose strengths. This transparent upfront pricing includes your medication and clinical consultation, with no hidden fees. New patients can Save £20 off their first order using code Weightlossnew, making low dose Wegovy even more accessible.

The cost-effectiveness of staying on low dose Wegovy compared to escalating to 2.4mg depends on your individual clinical situation. Lower doses are typically less expensive per pen, but if they prove insufficient for weight maintenance, you may require dose escalation anyway. Your prescriber will help you balance clinical effectiveness with cost considerations to find the optimal dosing strategy.

Cured Pharmacy guarantees the lowest Wegovy prices in the UK across all dose strengths. Our UK-registered pharmacy (GPhC 9012511) sources genuine licensed Wegovy directly from licensed wholesalers, ensuring product authenticity. Superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees all dispensing, and our clinical team provides ongoing support throughout your weight management journey.

Comparing Low Dose Wegovy Costs Over Time

When evaluating whether to stay on low dose Wegovy, consider the long-term cost implications. A patient maintaining on 0.5mg or 1mg weekly will have lower monthly medication costs than someone on 2.4mg. However, if the lower dose proves inadequate and you regain weight, you may face the cost of re-starting at higher doses or switching to alternative treatments.

Cured Pharmacy's pricing structure makes low dose Wegovy affordable for long-term use. We recommend discussing your dosing plan with your prescriber during your three-month review appointments to ensure you're receiving the most cost-effective dose that maintains your clinical results. Our team can provide pricing information for different dosing scenarios to help inform your decision.

Alternatives to Low Dose Wegovy for Weight Maintenance

If low dose Wegovy proves insufficient for maintaining your weight loss, several alternatives exist within the GLP-1 receptor agonist class and beyond. Wegovy Oral Tablets (semaglutide pill) offer a non-injection alternative starting from £69.00 which some patients find more convenient for long-term use. The oral formulation may have different dose-response characteristics, and some patients achieve maintenance on oral semaglutide after using injectable Wegovy [3].

Saxenda (liraglutide 3mg) represents another GLP-1 option for weight management, available from £69.00 at Cured Pharmacy. Whilst Saxenda requires daily injections compared to Wegovy's weekly dosing, some patients prefer the ability to adjust their dose more frequently based on appetite and tolerability. Liraglutide has a shorter half-life than semaglutide, which may suit patients who experienced persistent side effects on low dose Wegovy.

For patients who've successfully lost weight but struggle to maintain it on low dose Wegovy, combining a lower pharmacological dose with structured lifestyle support may prove effective. This might include dietitian support, behavioural therapy, or joining a structured weight management programme. Your prescriber can refer you to appropriate NHS or private services to complement your medication regimen.

How to Access Low Dose Wegovy Through Cured Pharmacy

Accessing low dose Wegovy through Cured Pharmacy is straightforward and takes under three minutes. Begin by completing our online clinical assessment, which covers your medical history, current medications, weight loss goals, and previous experience with Wegovy or other GLP-1 medications. Be specific about your current dose, how long you've been taking it, and your weight maintenance results to date.

A UK-registered prescriber will review your assessment, typically within 24 hours. If you're requesting to continue on low dose Wegovy rather than escalating, provide details of your weight loss percentage, current BMI, and any side effects experienced at higher doses. The prescriber may approve continuation at your current low dose, recommend escalation, or suggest an alternative approach based on your clinical presentation [2].

Once approved, your low dose Wegovy prescription is dispensed by our GPhC-registered pharmacy and dispatched in discreet packaging with next-day delivery options available. All Wegovy supplied by Cured Pharmacy is genuine UK-licensed medication stored and handled according to MHRA requirements. Our clinical team remains available for ongoing support, and you'll receive reminders for your regular review appointments to monitor your progress on low dose Wegovy maintenance.

Ongoing Clinical Monitoring on Low Dose Wegovy

Staying on low dose Wegovy requires regular clinical monitoring to ensure continued safety and effectiveness. Cured Pharmacy's clinical team conducts review consultations every three months, assessing your weight trajectory, any side effects, and overall treatment satisfaction. These reviews are essential for detecting early weight regain or tolerability issues that might necessitate dose adjustment.

During your reviews, we'll evaluate whether your current low dose Wegovy regimen continues to meet your clinical needs. If you've maintained stable weight loss and good tolerability, continuation is typically supported. If weight regain exceeds 5% of your lowest achieved weight, your prescriber may recommend dose escalation or additional interventions. This personalised monitoring ensures your low dose Wegovy use remains clinically appropriate over time.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
2. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE. [accessed 15 August 2026]
3. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., ... & Wadden, T. A. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: The STEP 4 randomized clinical trial. JAMA, 325(14), 1414-1425. [accessed 15 August 2026]
4. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
5. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
6. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.